Advertisement

Topics

Ligand Pharmaceuticals Company Profile

02:13 EST 19th December 2018 | BioPortfolio

Ligand is an emerging specialty pharmaceutical company that discovers, develops and markets innovative small molecule drugs to address critical, unmet medical needs. Ligand markets four oncology and dermatology products in the United States – ONTAK®, Targretin® capsules, Targretin® gel and Panretin® gel. Ligand launched its fifth product, AVINZA™, a treatment for chronic, moderate-to-severe pain, in the second quarter of this year. In addition, Ligand's network of major pharmaceutical partners is developing products for men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's robust R&D pipeline is based on the company's leadership in gene transcription technology.

Location

10275 Science Center Drive
San Diego
CA
92121-1117
United States of America

Contact

Phone: 858 550 7500
Fax: 858 550 7506
Email: investors@ligand.com


News Articles [418 Associated News Articles listed on BioPortfolio]

M&As this week: Ligand Pharmaceuticals, CVS Health, Mundipharma

Ligand Pharmaceuticals has acquired Vernalis for $42.3m giving the former access to a portfolio of eight fully funded programmes, as...Read More... The post M&As this week: Ligand Pharmaceuticals...

Ligand Pharmaceuticals Inc Q2 adjusted earnings Beat Estimates

WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc (LGND) revealed earnings for its second quarter that rose from last year.The company's profit totaled $73.16 million, or $2.99 per share. This com...

Ligand Pharmaceuticals Inc Q3 adjusted earnings Beat Estimates

WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc (LGND) released earnings for its third quarter that climbed from last year.The company's profit totaled $67.36 million, or $2.80 per share. This c...

Ligand Pharma Makes Offer To Buy Vernalis For About $43 Mln In Cash

LONDON (dpa-AFX) - Ligand Pharmaceuticals Inc. (LGND)and Vernalis plc (VER.L) announce that Ligand has declared its firm intention to acquire the entire issued and to be issued shares of Vernalis ...

With Vernalis Buy, Ligand Adds to Portfolio, Establishes U.K. Presence

Ligand Pharmaceuticals said Wednesday that its acquisition of U.K.-based biotech Vernalis has closed. The $42.3 million deal netted the San Diego company eight partner programs and a 70-person R&D...

Deals this week: Mundipharma, Ligand Pharmaceuticals

Mundipharma has signed an agreement with Kolon Life Sciences to secure rights for osteoarthritis therapy Invossa in Japan. The agreement...Read More... The post Deals this week: Mundipharma, Ligand Ph...

Ligand Announces OmniAb Partnership with iMetabolic Biopharma

Ligand Pharmaceuticals (NASDAQ:LGND) announces it has entered into a worldwide OmniAb partnership with iMetabolic Biopharma (iMBP), an early stage biopharma company located in Tempe, AZ. Under the ter...

Ligand Makes $43 Million Bid for Vernalis

US biopharma Ligand Pharmaceuticals has announced its intention to buy UK biotech Vernalis for approximately $43 million.

Drugs and Medications [275 Associated Drugs and Medications listed on BioPortfolio]

Targretin (bexarotene) capsules, 75 mg [Cardinal Health]

Targretin (bexarotene) capsules, 75 mg

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

PubMed Articles [773 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Highly Effective Removal of Nonsteroidal Anti-inflammatory Pharmaceuticals from Water by Zr(IV)-Based Metal-Organic Framework: Adsorption Performance and Mechanisms.

Nonsteroidal anti-inflammatory pharmaceuticals are emerging organic micropollutants in surface water, groundwater, and wastewater, whose removal is very important yet challenging. As a new class of po...

Using Fluorescence Anisotropy for Ligand Binding Kinetics of Membrane Proteins.

Determining ligand binding kinetics provides an indirect route to probe the functional capabilities of the binding pocket of a membrane protein receptor. Presented in this unit are four ligand-binding...

Clinical Trials [448 Associated Clinical Trials listed on BioPortfolio]

Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

The study aims at defining the role of soluble CD95 Ligand in the physiopathology of a rare group of inflammatory diseases: ANCA associated vasculitis. Soluble CD95 Ligand might have a pro...

Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

RATIONALE: Biological therapies such as flt3L and CD40-ligand use different ways to stimulate the immune system and stop cancer cells from growing. Biological therapy may be an effective t...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

The trial is to evaluate the efficacy and safety of recombinant human Apo-2 ligand in treating patients with advanced retreated non-small cell lung cancer

Companies [1377 Associated Companies listed on BioPortfolio]

Ligand Pharmaceuticals

Ligand is an emerging specialty pharmaceutical company that discovers, develops and markets innovative small molecule drugs to address critical, unmet medical needs. Ligand markets four oncology and d...

Ligand Pharmaceuticals Incorporated

Ligand discovers and develops new drugs that address critical unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's, in...

Neurogen Corporation & Ligand Pharmaceuticals

Ligand discovers and develops new drugs that address critical unmet medical needs of patients with muscle wasting, frailty, hormone-related diseases, osteoporosis, inflammatory di...

Clinical Ligand Assay Society's

The Clinical Ligand Assay Society's mission is to establish and promote high standards in the science and application of ligand assay technology by encouraging research, educating practitioners, and f...

Crystax Pharmaceuticals S.L.

Crystax Pharmaceuticals is a leading structure-based drug discovery company providing a unique service to its partners. Crystax has developed an integrated discovery platform, from the identification ...

More Information about "Ligand Pharmaceuticals" on BioPortfolio

We have published hundreds of Ligand Pharmaceuticals news stories on BioPortfolio along with dozens of Ligand Pharmaceuticals Clinical Trials and PubMed Articles about Ligand Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ligand Pharmaceuticals Companies in our database. You can also find out about relevant Ligand Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


Corporate Database Quicklinks



Searches Linking to this Company Record